Epidiolex & PCa?: "Epidiolex ... was... - Advanced Prostate...

Advanced Prostate Cancer

22,351 members28,110 posts

Epidiolex & PCa?

pjoshea13 profile image
3 Replies

"Epidiolex ... was approved for medical use in the United States in June 2018 for treatment of two rare forms of childhood epilepsy, Lennox-Gastaut syndrome and Dravet syndrome. Cannabidiol is the first United States Food and Drug Administration (FDA)-approved drug derived from the Cannabis plant. It is made by GW Pharmaceuticals. In September 2018, Epidiolex was placed by the United States Drug Enforcement Administration (DEA) in Schedule V, the least restrictive schedule for controlled substances, notwithstanding Cannabis itself being in Schedule I of the Controlled Substances Act, for substances with "no currently accepted medical use"" [1]

***

UK Clinical Trial Aims to Understand Role of Cannabinoids in Prostate Cancer Treatment

"Cannabinoids have been widely used in medicines to control pain, nausea, and vomiting and to stimulate appetite, especially in cancer patients. As it is through effective research that we are able to understand and advance new options, the UK College of Medicine and Markey Cancer Center faculty are now looking to understand if there is a role for Cannabinoids in the treatment of a deadly cancer in men, prostate cancer." [2]

Use the link to read the rest.

I wondered when the drug was approved why the company had tested it on two conditions that would not make the investors rich? Cynic that I am, I'm wondering if they had bigger things in mind. Epidiolex is FDA-approved and no doubt men with PCa will be asking their docs to prescribe it off-label in advance of the trial findings.

-Patrick

[1] en.wikipedia.org/wiki/Canna...

[2] med.uky.edu/news/uk-clinica...

Written by
pjoshea13 profile image
pjoshea13
To view profiles and participate in discussions please or .
Read more about...
3 Replies
PhilipSZacarias profile image
PhilipSZacarias

The trial is listed on ClinicalTrial.gov (clinicaltrials.gov/ct2/show.... No dosage plan or range is given. PSA and testosterone levels are the primary end points.

I have researched CBD and found that it is difficult to achieve therapeutic concentrations when taken orally due to hepatic metabolism. IMO, it should be injected or administered via patches or suppositories. The trial may find some improvement in QOL (i.e., anxiety reduction), but I seriously doubt that a significant effect will be observed on PSA kinetics. Cheers, Phil

in reply toPhilipSZacarias

More info on CBD:

healthline.com/nutrition/cb...

I may have to start taking this for some of the other benefits listed. Waiting to see if you-know-who jumps all over us for considering this 'supplement'.

in reply to

I've been taking CBD oil and another supplement every day since early 2017, and I've been very pleased with my results so far.

Not what you're looking for?

You may also like...

Cannabidiol [CBD] - Epidiolex

A number of men have expressed interest in CBD (cannabidiol) for PCa. It is currently available...
pjoshea13 profile image

Enzalutamide-Resistant PCa & 5-LOX Inhibition.

New cell study below [1]. The name Jagadananda Ghosh may not ring a bell but he & Dr. Charles E....
pjoshea13 profile image

FDA approved drugs - is estrogen added, yet?

A blessing and curse of prostate cancer is it is often slow moving. The blessing and curse of the...
kreg001 profile image

Oncolytic Virus Therapy for Pca

I understand that there is research being conducted on the use of modified adenoviruses for use as...
PCSurvivor39 profile image

University of Kentucky Phase 1 trial of CBD oil For PCa BCR. Estimated study completion time September 2021.

A phase I, dose-expansion cohort study on the safety of a cannabidiol for biochemical recurrence in...
Graham49 profile image